In 2024, there have been increases in laboratory-confirmed infections caused by Mycoplasma pneumoniae worldwide. This case series highlights the increasing frequency of M. pneumoniae-positive PCR (polymerase chain reaction) specimens and an increased number of hospital admissions with M. pneumoniae clinical syndromes. Within this case series, we observed a change in the epidemiology and clinical burden of childhood M. pneumoniae disease in the post-COVID-19 era.
Journal article
2025-01-20T00:00:00+00:00
14
COVID-19, Mycoplasma pneumoniae, children, epidemiology, Humans, Pneumonia, Mycoplasma, COVID-19, Child, Male, Mycoplasma pneumoniae, Female, Child, Preschool, SARS-CoV-2, Adolescent, Infant, Hospitalization